source
- Anthropic CEO says AI’s biotech breakthrough may still be a decade away despite current hypeIn a recent on‑stage conversation, Matthew Herper interviewed Dario Amodei, the CEO and co‑founder of Anthropic, about the role of artificial intelligence in biotechnology. The discussion took plac…
- Ebola therapy development accelerates as multiple candidates enter early trialsA new wave of research teams are racing to develop a therapy for Ebola, according to the latest Morning Rounds newsletter. The article notes that several candidates are now moving into early‑stage…